Citations (349)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Wubetu Yihunie, Getinet Nibret & Yibeltal Aschale. (2023) Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review. Clinical Pharmacology: Advances and Applications 15, pages 77-98.
Read now
Read now
Lin Wang, Huanchun Xing, Shuai Guo, Wenbin Cao, Zinan Zhang, Lijuan Huang, Sui Xin, Yuan Luo, Yongan Wang & Jun Yang. (2023) Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity. Drug Delivery 30:1.
Read now
Read now
Mirza Muhammad Faran Ashraf Baig, Lok Yin Wong & Hongkai Wu. (2023) Development of mRNA nano-vaccines for COVID-19 prevention and its biochemical interactions with various disease conditions and age groups. Journal of Drug Targeting 0:0, pages 1-12.
Read now
Read now
Truc Ly Nguyen, Jorge Samuel Leon Magdaleno, Abdul Rajjak Shaikh, Kiattawee Choowongkomon, Vladimir Li, Youngho Lee & Heebal Kim. (2023) Designing a multi-epitope candidate vaccine by employing immunoinformatics approaches to control African swine fever spread. Journal of Biomolecular Structure and Dynamics 41:19, pages 10214-10229.
Read now
Read now
Muhammad Janees Imdad, Muhammad Naseem Khan, Hafiz Shahood Alam, Abdul Basit Khan, Zulfiqar Ali Mirani, Adnan Khan & Faraz Ahmed. (2023) Design and in silico analysis of mRNA vaccine construct against Salmonella. Journal of Biomolecular Structure and Dynamics 41:15, pages 7248-7264.
Read now
Read now
Dawood Ghafoor, Adnan Zeb, Syed Shujait Ali, Muhammad Ali, Fazal Akbar, Zia Ud Din, Shoaib Ur Rehman, Muhammad Suleman & Wajid Khan. (2023) Immunoinformatic based designing of potential immunogenic novel mRNA and peptide-based prophylactic vaccines against H5N1 and H7N9 avian influenza viruses. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now
Read now
Nabiha Tasneem Khan, Maliha Afroj Zinnia & Abul Bashar Mir Md. Khademul Islam. (2023) Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach. Journal of Biomolecular Structure and Dynamics 41:5, pages 1617-1638.
Read now
Read now
Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee & Mutia Masuka Muna. (2022) Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases. RNA Biology 19:1, pages 386-410.
Read now
Read now
Evalyne M Jansen, Henderik W Frijlink, Wouter LJ Hinrichs & Mitchel JR Ruigrok. (2022) Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opinion on Drug Delivery 19:11, pages 1471-1485.
Read now
Read now
Maryam Abbaspour & Vajihe Akbari. (2022) Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence. Expert Review of Vaccines 21:3, pages 337-353.
Read now
Read now
Chih-Yeu Fang & Chia-Chyi Liu. (2022) Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies. Expert Opinion on Drug Discovery 17:1, pages 27-39.
Read now
Read now
Małgorzata Kurkowiak, Giuseppa Grasso, Jakub Faktor, Lisa Scheiblecker, Małgorzata Winniczuk, Marcos Yebenes Mayordomo, J. Robert O’Neill, Bodil Oster, Borek Vojtesek, Ali Al-Saadi, Natalia Marek-Trzonkowska & Ted R. Hupp. (2021) An integrated DNA and RNA variant detector identifies a highly conserved three base exon in the MAP4K5 kinase locus. RNA Biology 18:12, pages 2556-2575.
Read now
Read now
Khalid Hajissa & Ali Mussa. (2021) Positive aspects of the mRNA platform for SARS-CoV-2 vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2445-2447.
Read now
Read now
Suangson Supabphol, Lijin Li, S. Peter Goedegebuure & William E. Gillanders. (2021) Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy. Expert Opinion on Investigational Drugs 30:5, pages 529-541.
Read now
Read now
Nitika, Jiao Wei & Ai-Min Hui. (2021) The Development of mRNA Vaccines for Infectious Diseases: Recent Updates. Infection and Drug Resistance 14, pages 5271-5285.
Read now
Read now
Elnaz Faghfuri, Farhad Pourfarzi, Amir Hossein Faghfouri, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh & Behzad Baradaran. (2021) Recent developments of RNA-based vaccines in cancer immunotherapy. Expert Opinion on Biological Therapy 21:2, pages 201-218.
Read now
Read now
Carlo Iavarone, Derek T. O’hagan, Dong Yu, Nicolas F. Delahaye & Jeffrey B. Ulmer. (2017) Mechanism of action of mRNA-based vaccines. Expert Review of Vaccines 16:9, pages 871-881.
Read now
Read now
Elias J. Sayour, Gabriel De Leon, Christina Pham, Adam Grippin, Hanna Kemeny, Joshua Chua, Jianping Huang, John H. Sampson, Luis Sanchez-Perez, Catherine Flores & Duane A. Mitchell. (2017) Systemic activation of antigen-presenting cells via RNA-loaded nanoparticles. OncoImmunology 6:1.
Read now
Read now
Karl Ljungberg & Peter Liljeström. (2015) Self-replicating alphavirus RNA vaccines. Expert Review of Vaccines 14:2, pages 177-194.
Read now
Read now
Sandra Van Lint, Dries Renmans, Katrijn Broos, Heleen Dewitte, Ine Lentacker, Carlo Heirman, Karine Breckpot & Kris Thielemans. (2015) The ReNAissanCe of mRNA-based cancer therapy. Expert Review of Vaccines 14:2, pages 235-251.
Read now
Read now
Daphné Benteyn, Carlo Heirman, Aude Bonehill, Kris Thielemans & Karine Breckpot. (2015) mRNA-based dendritic cell vaccines. Expert Review of Vaccines 14:2, pages 161-176.
Read now
Read now
Steffen Rausch, Christian Schwentner, Arnulf Stenzl & Jens Bedke. (2014) mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer. Human Vaccines & Immunotherapeutics 10:11, pages 3146-3152.
Read now
Read now
Raquel P Deering, Sushma Kommareddy, Jeffrey B Ulmer, Luis A Brito & Andrew J Geall. (2014) Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opinion on Drug Delivery 11:6, pages 885-899.
Read now
Read now
Karl-Josef Kallen, Regina Heidenreich, Margit Schnee, Benjamin Petsch, Thomas Schlake, Andreas Thess, Patrick Baumhof, Birgit Scheel, Sven D Koch & Mariola Fotin-Mleczek. (2013) A novel, disruptive vaccination technology. Human Vaccines & Immunotherapeutics 9:10, pages 2263-2276.
Read now
Read now
Articles from other publishers (325)
Maxwell D. Weidmann, M. Shaheen Malick, Anjali Saqi, Matthias J. Szabolcs, Susan J. Hsiao, Helen Fernandes & Alex J. Rai. 2024. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
199
216
.
Yu-Da Liu, Hao-Ran Chen, Yao Zhang, Ge Yan, Hao-Jie Yan, Qi Zhu & Li-Hua Peng. (2023) Progress and challenges of plant-derived nucleic acids as therapeutics in macrophage-mediated RNA therapy. Frontiers in Immunology 14.
Crossref
Crossref
Khizra Mujahid, Isra Rana, Ivan Hardianto Suliman, Zhen Li, Jiang Wu, Huacheng He & Jutaek Nam. (2023) Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy. ACS Applied Bio Materials.
Crossref
Crossref
Justin S. Antony, Pascale Birrer, Claudia Bohnert, Sina Zimmerli, Petra Hillmann, Hervé Schaffhauser, Christine Hoeflich, Andreas Hoeflich, Ramzi Khairallah, Andreas T. Satoh, Isabelle Kappeler, Isabel Ferreira, Klaas P. Zuideveld & Friedrich Metzger. (2023) Local application of engineered insulin-like growth factor I mRNA demonstrates regenerative therapeutic potential in vivo. Molecular Therapy - Nucleic Acids 34, pages 102055.
Crossref
Crossref
Lin-Jia Su, Mo-Xi Xu, Zi-Han Ji, Jia-Qing Zhu, Meng-Zhen Yu, Yi Wang & Yao-Xin Lin. (2023) Delivery of mRNA for cancer therapy: progress and prospects. Nano Today 53, pages 102013.
Crossref
Crossref
Cong Geng, Kefan Zhou, Ying Yan, Chan Li, Beibei Ni, Jiangman Liu, Yeming Wang, Xiaoyan Zhang, Dazhuang Wang, Lu Lv, Yongchuan Zhou, Anhua Feng, Yajuan Wang & Chunlei Li. (2023) A preparation method for mRNA-LNPs with improved properties. Journal of Controlled Release 364, pages 632-643.
Crossref
Crossref
Yannick Borkens. (2023) Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South. Acta Parasitologica 68:4, pages 916-928.
Crossref
Crossref
H. S. Jeffrey Man, Vaneeza A. Moosa, Anand Singh, Licun Wu, John T. Granton, Stephen C. Juvet, Chuong D. Hoang & Marc de Perrot. (2023) Unlocking the potential of RNA-based therapeutics in the lung: current status and future directions. Frontiers in Genetics 14.
Crossref
Crossref
Ryo Okuyama. (2023) mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions. Vaccines 11:12, pages 1737.
Crossref
Crossref
Sarfaraz K. Niazi & Matthias Magoola. (2023) mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option. Biologics 3:4, pages 355-379.
Crossref
Crossref
Mohibullah Shah, Samavia Jaan, Muhammad Shehroz, Asifa Sarfraz, Khamna Asad, Tehreem Ul Wara, Aqal Zaman, Riaz Ullah, Essam A. Ali, Umar Nishan & Suvash Chandra Ojha. (2023) Deciphering the Immunogenicity of Monkeypox Proteins for Designing the Potential mRNA Vaccine. ACS Omega 8:45, pages 43341-43355.
Crossref
Crossref
Venkatesan Saravanan, Bharath Kumar Chagaleti, Pavithra Lakshmi Narayanan, Vijay Babu Anandan, Haritha Manoharan, G.V. Anjana, Ramalingam Peraman, S. Karthik Raja Namasivayam, M. Kavisri, Jesu Arockiaraj, Kathiravan Muthu Kumaradoss & Meivelu Moovendhan. (2023)
Discovery and development of
COVID
‐19 vaccine from laboratory to clinic
. Chemical Biology & Drug Design.
Crossref
Crossref
Qiao Hongtu, Liu BoLi, Chen Jianguo, Peng Shusheng & Min Ming. (2023) Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice. Vaccine 41:48, pages 7129-7137.
Crossref
Crossref
Saurav Kumar Jha, Mohammad Imran, Laxmi Akhileshwar Jha, Nazeer Hasan, Vijay Kumar Panthi, Keshav Raj Paudel, Waleed H. Almalki, Yousuf Mohammed & Prashant Kesharwani. (2023) A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response. Environmental Research 236, pages 116823.
Crossref
Crossref
Xiaoqing Liu, Pei Huang, Rusen Yang & Hongzhang Deng. (2023) mRNA Cancer Vaccines: Construction and Boosting Strategies. ACS Nano 17:20, pages 19550-19580.
Crossref
Crossref
Xanthippi Topalidou, Alexis M. Kalergis & Georgios Papazisis. (2023) Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines. Pathogens 12:10, pages 1259.
Crossref
Crossref
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova & Dmitri V. Krysko. (2023) In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future. Vaccines 11:10, pages 1600.
Crossref
Crossref
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, Aklank Jain, P. Hemachandra Reddy, Gurjit Kaur Bhatti & Jasvinder Singh Bhatti. (2023) Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach. Advanced Therapeutics.
Crossref
Crossref
Yu-Shiuan Wang, Monika Kumari, Guan-Hong Chen, Ming-Hsiang Hong, Joyce Pei-Yi Yuan, Jui-Ling Tsai & Han-Chung Wu. (2023) mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications. Journal of Biomedical Science 30:1.
Crossref
Crossref
Tian Tan, Shu-Ting Deng, Bing-Huo Wu, Qi Yang, Meng-Wan Wu, Hong Wu, Chen-Hui Cao & Chuan Xu. (2023) mRNA Vaccine - A New Cancer Treatment Strategy. Current Cancer Drug Targets 23:9, pages 669-681.
Crossref
Crossref
Karol Kurpiejewski, Marzena Jankowska-Anyszka & Renata Grzela. (2023) N2 modified cap analogues as translation inhibitors and substrates for preparation of therapeutic mRNA. European Biophysics Journal 52:6-7, pages 511-519.
Crossref
Crossref
Mujie Yuan, Zeyu Han, Yan Liang, Yong Sun, Bin He, Wantao Chen & Fan Li. (2023) mRNA nanodelivery systems: targeting strategies and administration routes. Biomaterials Research 27:1.
Crossref
Crossref
Yahya F Jamous & Dalal A Alhomoud. (2023) The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2. Cureus.
Crossref
Crossref
Ahmet Hınçer, Recep Erdem Ahan, Ebru Aras & Urartu Özgür Şafak Şeker. (2023) Making the Next Generation of Therapeutics: mRNA Meets Synthetic Biology. ACS Synthetic Biology 12:9, pages 2505-2515.
Crossref
Crossref
Inseong Choi, Guk-Young Ahn, Eun Seo Kim, Se Hee Hwang, Hyo-Jung Park, Subin Yoon, Jisun Lee, Youngran Cho, Jae-Hwan Nam & Sung-Wook Choi. (2023) Microfluidic Bioreactor with Fibrous Micromixers for In Vitro mRNA Transcription. Nano Letters 23:17, pages 7897-7905.
Crossref
Crossref
Sonal Gupta & Sabine Pellett. (2023) Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines. Toxins 15:9, pages 563.
Crossref
Crossref
Chenyuan Ji. (2023) Research on the advantages and disadvantages and the challenges of mRNA vaccines: taking the COVID-19 mRNA vaccine as an example. Research on the advantages and disadvantages and the challenges of mRNA vaccines: taking the COVID-19 mRNA vaccine as an example.
Akanksha Jain, Sonia Bajaj, Parag Jain, Ashish Majumdar, Ayushi Singh & Pranay Soni. (2023) A review on biotechnologically derived techniques to combat COVID-19 situation. Health Sciences Review 8, pages 100112.
Crossref
Crossref
Xue Feng, Zhiguo Su, Yuan Cheng, Guanghui Ma & Songping Zhang. (2023) Messenger RNA chromatographic purification: advances and challenges. Journal of Chromatography A 1707, pages 464321.
Crossref
Crossref
Chabungbam Dhurbachandra Singh, Kazi Morshed Alom, Dinesh Kumar Kannan, Thokchom Simander Singh, Subhashish Samantaray, Guralamatta Siddappa Ravi Kumara & Young Jun Seo. (2023) mRNA incorporation of C(5)-halogenated pyrimidine ribonucleotides and induced high expression of corresponding protein for the development of mRNA vaccine. Bioorganic Chemistry, pages 106897.
Crossref
Crossref
Satyendra Prakash. (2023) mRNA-Based Nanomedicine: A New Strategy for Treating Infectious Diseases and Beyond. European Journal of Drug Metabolism and Pharmacokinetics 48:5, pages 515-529.
Crossref
Crossref
Meng‐Zhen Yu, Nan‐Nan Wang, Jia‐Qing Zhu & Yao‐Xin Lin. (2023)
The clinical progress and challenges of
mRNA
vaccines
. WIREs Nanomedicine and Nanobiotechnology 15:5.
Crossref
Crossref
Zhongfeng Ye, Joseph Harmon, Wei Ni, Yamin Li, Douglas Wich & Qiaobing Xu. (2023) The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology. ACS Nano 17:16, pages 15231-15253.
Crossref
Crossref
Yanhao Zhang, Ji Wang, Hanlei Xing, Chao Liu, Wenhui Zha, Shuo Dong, Yuhao Jiang & Xinsong Li. (2023) Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection. Journal of Materials Chemistry B 11:31, pages 7454-7465.
Crossref
Crossref
Anna Jéssica Duarte Silva, Mylenna Máyra Gois de Sousa, Larissa Silva de Macêdo, Pedro Luiz de França Neto, Ingrid Andrêssa de Moura, Benigno Cristofer Flores Espinoza, Maria Da Conceição Viana Invenção, Samara Sousa de Pinho, Marco Antonio Turiah Machado da Gama & Antonio Carlos de Freitas. (2023) RNA Vaccines: Yeast as a Novel Antigen Vehicle. Vaccines 11:8, pages 1334.
Crossref
Crossref
Zhengjie ZHOU & Xin LI. (2023) Research progress in mRNA drug modification and delivery systems. Journal of Zhejiang University (Medical Sciences) 52:4, pages 439-450.
Crossref
Crossref
Qinyi DOU, Jiazheng WANG, Yingshuo YANG & Wei ZHUO. (2023) Roles of exosome-derived non-coding RNA in tumor micro-environment and its clinical application. Journal of Zhejiang University (Medical Sciences) 52:4, pages 429-438.
Crossref
Crossref
Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, Selma Zargari, Farzaneh Alizadeh, Mahyar Dorrigiv, Asghar Abdoli, Hossein Aminianfar, Mahdi Hatamipour, Javad Zarqi, Saeed Behboodifar, Yalda Samsami, Saeideh Khorshid Sokhangouy, Yahya Sefidbakht, Vuk Uskoković, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari & Sina Mozaffari-Jovin. (2023) Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates. Journal of Controlled Release 360, pages 316-334.
Crossref
Crossref
Li Zhuang, Zhaoyang Ye, Linsheng Li, Ling Yang & Wenping Gong. (2023) Next-Generation TB Vaccines: Progress, Challenges, and Prospects. Vaccines 11:8, pages 1304.
Crossref
Crossref
Jędrzej Warpechowski, Paula Leszczyńska, Dominika Juchnicka, Adam Olichwier, Łukasz Szczerbiński & Adam Jacek Krętowski. (2023) Assessment of the Immune Response in Patients with Insulin Resistance, Obesity, and Diabetes to COVID-19 Vaccination. Vaccines 11:7, pages 1203.
Crossref
Crossref
Xiaolin Xu, Wencai Guan, Xiaolei Yu, Guoxiong Xu & Chenglong Wang. (2023) Non-interfacial self-assembly of synthetic protocells. Biomaterials Research 27:1.
Crossref
Crossref
Ji Wang, Yanhao Zhang, Shuo Dong, Wenhui Zha, Chao Liu, Yang Wang, Yuhao Jiang, Hanlei Xing & Xinsong Li. (2023) Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles. International Journal of Pharmaceutics 642, pages 123155.
Crossref
Crossref
Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao & Shubiao Zhang. (2023) Development and applications of mRNA treatment based on lipid nanoparticles. Biotechnology Advances 65, pages 108130.
Crossref
Crossref
Nicholas J. Tursi, Ziyang Xu, Daniel W. Kulp & David B. Weiner. (2023) Gene‐encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Crossref
Yukai Huang, Xuerui Zhu, Xiao Guo, Yuancheng Zhou, Dongying Liu, Jingrui Mao, Yongai Xiong, Youcai Deng & Xinghong Gao. (2023) Advances in mRNA vaccines for viral diseases. Journal of Medical Virology 95:7.
Crossref
Crossref
Bhatia Sudhir. (2023) LOSS OF AN ABUNDANT QUANTITY OF RIBONUCLEIC ACID DURING MINI COLUMN ISOLATION METHOD. Biotechnologia Acta 16:3, pages 65-69.
Crossref
Crossref
Baochao Fan, Jun Gu, Bin Deng, Weilu Guo, Shuaifeng Zhang, Li Li & Bin Li. (2023) Positively Charged-Amylose-Entangled Au-Nanoparticles Acting as Protein Carriers and Potential Adjuvants to SARS-CoV-2 Subunit Vaccines. ACS Applied Materials & Interfaces 15:25, pages 29982-29997.
Crossref
Crossref
Daniel Lozano, Vicente Larraga, María Vallet-Regí & Miguel Manzano. (2023) An Overview of the Use of Nanoparticles in Vaccine Development. Nanomaterials 13:12, pages 1828.
Crossref
Crossref
Hiroshi Nakayama & Masato Taoka. (2023) Characterization of mRNA Therapeutics by Isotope-Dilution Liquid Chromatography–Mass SpectrometrymRNA医薬品の同位体希釈–液体クロマトグラフィー–質量分析による特性解析. Journal of the Mass Spectrometry Society of Japan 71:2, pages 69-74.
Crossref
Crossref
Miao Jiang, Elina Väisänen, Pekka Kolehmainen, Moona Huttunen, Seppo Ylä-Herttuala, Seppo Meri, Pamela Österlund & Ilkka Julkunen. (2023) COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs. Vaccine 41:26, pages 3813-3823.
Crossref
Crossref
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, S. Princely Ebenezer Gnanakani, Pavani Sure, R. Vijayalakshmi, V.D. Sundar, Versha Sharma, Ruchita Antil, Megha Jha, Sunita Minz, Anindya Bagchi & Madhulika Pradhan. (2023) Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: Mechanistic challenges, delivery strategies, and therapeutic applications. International Journal of Biological Macromolecules 241, pages 124582.
Crossref
Crossref
Yifan Jin, Addeela Fayyaz, Ayesha Liaqat, Abbas Khan, Abdulrahman Alshammari, Yanjing Wang, Ruo-Xu Gu & Dong-Qing Wei. (2023) Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreak. Computers in Biology and Medicine 159, pages 106893.
Crossref
Crossref
E. Sumeyra Turali‐Emre, Ahmet E. Emre, Drew A. Vecchio, Usha Kadiyala, J. Scott VanEpps & Nicholas A. Kotov. (2023) Self‐Organization of Iron Sulfide Nanoparticles into Complex Multicompartment Supraparticles. Advanced Materials 35:23.
Crossref
Crossref
Ana Ayala Pazzi, Puneet Vij, Nura Salhadar, Elias George & Manish K. Tripathi. 2023. RNA Therapeutics - History, Design, Manufacturing, and Applications. RNA Therapeutics - History, Design, Manufacturing, and Applications.
Moh Egy Rahman Firdaus, Apon Zaenal Mustopa, Nurlaili Ekawati, Sheila Chairunnisa, Rosyida Khusniatul Arifah, Ai Hertati, Shasmita Irawan, Anika Prastyowati, Arizah Kusumawati & Maritsa Nurfatwa. (2023) Optimization, characterization, comparison of self-assembly VLP of capsid protein L1 in yeast and reverse vaccinology design against human papillomavirus type 52. Journal of Genetic Engineering and Biotechnology 21:1.
Crossref
Crossref
Mai Komori, Takuto Nogimori, Amber L. Morey, Takashi Sekida, Keiko Ishimoto, Matthew R. Hassett, Yuji Masuta, Hirotaka Ode, Tomokazu Tamura, Rigel Suzuki, Jeff Alexander, Yasutoshi Kido, Kenta Matsuda, Takasuke Fukuhara, Yasumasa Iwatani, Takuya Yamamoto, Jonathan F. Smith & Wataru Akahata. (2023) saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature Communications 14:1.
Crossref
Crossref
Matthew T. J. Halma, Christof Plothe, Paul Marik & Theresa A. Lawrie. (2023) Strategies for the Management of Spike Protein-Related Pathology. Microorganisms 11:5, pages 1308.
Crossref
Crossref
Deepti Katiyar. (2023) Applications of intelligent biomaterials in cancer immunotherapy: A review. Materials Today: Proceedings.
Crossref
Crossref
Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta Naik, Jeremy P. Kamil, Anthony Gitter, Casey S. Greene, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Capone, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Jesse G. Meyer, Ariel I. Mundo, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang & Nils Wellhausen. (2023) The Coming of Age of Nucleic Acid Vaccines during COVID-19. mSystems 8:2.
Crossref
Crossref
Sarfaraz K. Niazi. (2023) RNA Therapeutics: A Healthcare Paradigm Shift. Biomedicines 11:5, pages 1275.
Crossref
Crossref
Martin Egli & Muthiah Manoharan. (2023) Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Research 51:6, pages 2529-2573.
Crossref
Crossref
Min Tang, Ayane Sagawa, Nodoka Inoue, Satomi Torii, Kana Tomita & Yoshiyuki Hattori. (2023) Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method. Pharmaceutics 15:4, pages 1141.
Crossref
Crossref
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, Ali Kamedi, Andrew O’ Neill, Ronan MacLoughlin & Mohammad Doroudian. (2023) Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections. Pharmaceutics 15:4, pages 1127.
Crossref
Crossref
Mona Sadat Mirtaleb, Reza Falak, Jalal Heshmatnia, Behnaz Bakhshandeh, Ramezan Ali Taheri, Hoorieh Soleimanjahi & Reza Zolfaghari Emameh. (2023) An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations. International Immunopharmacology 117, pages 109934.
Crossref
Crossref
Roghayyeh Baghban, Abdolmajid Ghasemian & Shirin Mahmoodi. (2023) Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19). Archives of Microbiology 205:4.
Crossref
Crossref
Jürgen Beck, Matthias Biechele, Christoph Repik, Petra Gruber, Paul G. Furtmüller & Rainer Hahn. (2023) Desorption of plasmid DNA from anion exchangers: Salt concentration at elution is independent of plasmid size and load. Journal of Separation Science 46:8.
Crossref
Crossref
Hong You, Malcolm K. Jones, Catherine A. Gordon, Alexa E. Arganda, Pengfei Cai, Harry Al-Wassiti, Colin W. Pouton & Donald P. McManus. (2023) The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections. Clinical Microbiology Reviews 36:1.
Crossref
Crossref
Junchen Zhang. (2023) The emerging role of vaccines in cancer therapies. Highlights in Science, Engineering and Technology 36, pages 1427-1432.
Crossref
Crossref
Michael Kozak & Jiafen Hu. (2023) The Integrated Consideration of Vaccine Platforms, Adjuvants, and Delivery Routes for Successful Vaccine Development. Vaccines 11:3, pages 695.
Crossref
Crossref
Jaeyoung Park & Julie A. Champion. (2023) Effect of Antigen Structure in Subunit Vaccine Nanoparticles on Humoral Immune Responses. ACS Biomaterials Science & Engineering 9:3, pages 1296-1306.
Crossref
Crossref
Doris Lambracht-Washington, Min Fu, Mary Wight-Carter, Matthew Riegel, Linda S. Hynan & Roger N. Rosenberg. (2023) DNA Aβ42 immunization via needle-less Jet injection in mice and rabbits as potential immunotherapy for Alzheimer's disease. Journal of the Neurological Sciences 446, pages 120564.
Crossref
Crossref
Yunchao Zhang, Chenxin Liu, Chunjie Wu & Linjiang Song. (2023) Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives. Biomedicine & Pharmacotherapy 159, pages 114257.
Crossref
Crossref
Annika Beck, Hanna Dietenberger, Sebastian N. Kunz, Kevin Mellert & Peter Möller. (2023) Emergence of SARS‐CoV‐2 spike protein at the vaccination site. Immunity, Inflammation and Disease 11:3.
Crossref
Crossref
Alexander Avdoshin, Vladimir Naumov, Lucio Colombi Ciacchi, Stanislav Ignatov & Susan Köppen. (2023) Atomistic simulations of chitosan as a possible carrier system for miRNA transport. Materials Advances 4:4, pages 1113-1124.
Crossref
Crossref
Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad & Ravinder Kumar. (2023) Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery. Vaccines 11:2, pages 479.
Crossref
Crossref
He Xian, Yue Zhang, Chengzhong Yu & Yue Wang. (2023) Nanobiotechnology-Enabled mRNA Stabilization. Pharmaceutics 15:2, pages 620.
Crossref
Crossref
Werner Krause. (2023) mRNA—From COVID-19 Treatment to Cancer Immunotherapy. Biomedicines 11:2, pages 308.
Crossref
Crossref
Androulla N. Miliotou, Parthena F. Foltopoulou, Alexandra Ingendoh-Tsakmakidis, Asterios S. Tsiftsoglou, Ioannis S. Vizirianakis, Ioannis S. Pappas & Lefkothea C. Papadopoulou. (2023) Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency. Pharmaceutics 15:1, pages 286.
Crossref
Crossref
Christin Schmidt & Barbara S. Schnierle. (2023) Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development. Pathogens 12:1, pages 138.
Crossref
Crossref
Yongguang Gao, Xinhua Liu, Na Chen, Xiaochun Yang & Fang Tang. (2023) Recent Advance of Liposome Nanoparticles for Nucleic Acid Therapy. Pharmaceutics 15:1, pages 178.
Crossref
Crossref
Theofanis Vavilis, Eleni Stamoula, Alexandra Ainatzoglou, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas & Ioannis S. Vizirianakis. (2023) mRNA in the Context of Protein Replacement Therapy. Pharmaceutics 15:1, pages 166.
Crossref
Crossref
Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari & Mrinal K. Ghosh. (2022) COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology 89:1, pages 114-149.
Crossref
Crossref
Walid Azab. 2023. Antimicrobial Activity of Nanoparticles. Antimicrobial Activity of Nanoparticles
133
154
.
Mengjie Zhang, Abid Hussain, Haiyin Yang, Jinchao Zhang, Xing-Jie Liang & Yuanyu Huang. (2022) mRNA-based modalities for infectious disease management. Nano Research 16:1, pages 672-691.
Crossref
Crossref
Simav Gildiz & Tamara Minko. (2022) Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer. Pharmaceutical Research 40:1, pages 123-144.
Crossref
Crossref
Simran Saikia, Shreya Barman, S. Sudhimon, M. Mukesh Kumar, G. Shanmugasundaram & J. Sudagar. 2023. Advanced Nanomaterials and Their Applications. Advanced Nanomaterials and Their Applications
111
123
.
Patric U. B. VogelPatric U. B. Vogel. 2023. COVID-19: Search for a vaccine. COVID-19: Search for a vaccine
29
34
.
Tuğçe DURAN, Naci ÇİNE, Nadir KOÇAK & Saliha KURT. (2022) Optimization of High Concentration Plasmid DNA for Use in COVID-19 mRNA Vaccine Development: Comparison of Between Alkaline Lysis Method and Commercial Kit ResultsCOVID-19 mRNA Aşı Geliştirilmesinde Kullanılacak Olan Yüksek Konsantrasyondaki Plazmid DNA’sının Optimizasyonu: Alkalen Lizis Metodu ve Ticari Kit Sonuçlarının Kıyaslanması. Harran Üniversitesi Veteriner Fakültesi Dergisi 11:2, pages 154-161.
Crossref
Crossref
Yasaman Mohammadi, Navid Nezafat, Manica Negahdaripour, Sedigheh Eskandari & Mozhdeh Zamani. (2022) In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach. Immunologic Research.
Crossref
Crossref
Hiroshi Nakayama, Yuko Nobe, Masami Koike & Masato Taoka. (2022) Liquid Chromatography–Mass Spectrometry-Based Qualitative Profiling of mRNA Therapeutic Reagents Using Stable Isotope-Labeled Standards Followed by the Automatic Quantitation Software Ariadne. Analytical Chemistry.
Crossref
Crossref
Jacques Demongeot & Cécile Fougère. (2022) mRNA COVID-19 Vaccines—Facts and Hypotheses on Fragmentation and Encapsulation. Vaccines 11:1, pages 40.
Crossref
Crossref
Vivek P. Chavda, Shailvi Soni, Lalitkumar K. Vora, Shruti Soni, Avinash Khadela & Jinal Ajabiya. (2022) mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. Vaccines 10:12, pages 2150.
Crossref
Crossref
Shyh Poh Teo. (2021) Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273. Journal of Pharmacy Practice 35:6, pages 947-951.
Crossref
Crossref
Akbar Hasanzadeh, Michael R. Hamblin, Jafar Kiani, Hamid Noori, Joseph M. Hardie, Mahdi Karimi & Hadi Shafiee. (2022) Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?. Nano Today 47, pages 101665.
Crossref
Crossref
Wenhao O. Ouyang, Timothy J.C. Tan, Ruipeng Lei, Ge Song, Collin Kieffer, Raiees Andrabi, Kenneth A. Matreyek & Nicholas C. Wu. (2022) Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning. Science Advances 8:47.
Crossref
Crossref
Mamuna Mukhtar, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi & Naseeha Bibi. (2022) Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches. International Journal of Molecular Sciences 23:22, pages 13911.
Crossref
Crossref
Lakshman Perera Samaranayake, Chaminda Jayampath Seneviratne & Kausar Sadia Fakhruddin. (2021) Coronavirus disease 2019 (COVID‐19) vaccines: A concise review. Oral Diseases 28:S2, pages 2326-2336.
Crossref
Crossref
Eduarde Rohner, Ran Yang, Kylie S. Foo, Alexander Goedel & Kenneth R. Chien. (2022) Unlocking the promise of mRNA therapeutics. Nature Biotechnology 40:11, pages 1586-1600.
Crossref
Crossref
Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen & Wei He. (2022) Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Yuchen Wang, Lin Ling, Zilei Zhang & Alejandro Marin-Lopez. (2022) Current Advances in Zika Vaccine Development. Vaccines 10:11, pages 1816.
Crossref
Crossref
Yen-Pin Lin, Yi-Shan Hsieh, Mei-Hsiu Cheng, Ching-Fen Shen, Ching-Ju Shen & Chao-Min Cheng. (2022) Using MicroRNA Arrays as a Tool to Evaluate COVID-19 Vaccine Efficacy. Vaccines 10:10, pages 1681.
Crossref
Crossref
Sally A. Helmy, Rasha M. El-Morsi, Soha A.M. Helmy & Soha M. El-Masry. (2022) Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations. Journal of Drug Delivery Science and Technology 76, pages 103762.
Crossref
Crossref
Huijung Kim, Kübra Solak, Yoojoong Han, Yeon-Woo Cho, Kyeong-Mo Koo, Chang-Dae Kim, Zhengtang Luo, Hyungbin Son, Hyung-Ryong Kim, Ahmet Mavi & Tae-Hyung Kim. (2022) Electrically controlled mRNA delivery using a polypyrrole-graphene oxide hybrid film to promote osteogenic differentiation of human mesenchymal stem cells. Nano Research 15:10, pages 9253-9263.
Crossref
Crossref
Massimiliano Chetta, Marina Tarsitano, Maria Oro, Maria Rivieccio & Nenad Bukvic. (2022) An in silico pipeline approach uncovers a potentially intricate network involving spike SARS-CoV-2 RNA, RNA vaccines, host RNA-binding proteins (RBPs), and host miRNAs at the cellular level. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Crossref
Yannick Borkens. (2022) Malaria-Antigene in der Ära der mRNA-ImpfstoffeMalarial antigens in the era of mRNA vaccines. Monatsschrift Kinderheilkunde 170:9, pages 828-838.
Crossref
Crossref
Tao Huang, Lushan Peng, Yingying Han, Dan Wang, Xiaoyun He, Junpu Wang & Chunlin Ou. (2022) Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects. Frontiers in Immunology 13.
Crossref
Crossref
Nitika, Jiao Wei & Ai-Min Hui. (2022) The Delivery of mRNA Vaccines for Therapeutics. Life 12:8, pages 1254.
Crossref
Crossref
Lorentz Jäntschi. (2022) Introducing Structural Symmetry and Asymmetry Implications in Development of Recent Pharmacy and Medicine. Symmetry 14:8, pages 1674.
Crossref
Crossref
Jarett J. Casale, Mikél E. Muse, Tara J. Snow, Karen P. Gould & Natalie D. Depcik-Smith. (2022) Leukocytoclastic Vasculitis following the First Dose of the Elasomeran COVID-19 Vaccination. Case Reports in Dermatological Medicine 2022, pages 1-3.
Crossref
Crossref
Olugbenga Oluwagbemi, Elijah Oladipo, Olatunji Kolawole, Julius Oloke, Temitope Adelusi, Boluwatife Irewolede, Emmanuel Dairo, Ayodele Ayeni, Kehinde Kolapo, Olawumi Akindiya, Jerry Oluwasegun, Bamigboye Oluwadara & Segun Fatumo. (2022) Bioinformatics, Computational Informatics, and Modeling Approaches to the Design of mRNA COVID-19 Vaccine Candidates. Computation 10:7, pages 117.
Crossref
Crossref
Qing He, Hua Gao, Dejiang Tan, Heng Zhang & Jun-zhi Wang. (2022) mRNA cancer vaccines: Advances, trends and challenges. Acta Pharmaceutica Sinica B 12:7, pages 2969-2989.
Crossref
Crossref
Sodiq A. Hameed, Stephane Paul, Giann Kerwin Y. Dellosa, Dolores Jaraquemada & Muhammad Bashir Bello. (2022) Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies. npj Vaccines 7:1.
Crossref
Crossref
Navya Bellamkonda, Upendra Pradeep Lambe, Sonali Sawant, Shyam Sundar Nandi, Chiranjib Chakraborty & Deepak Shukla. (2022) Immune Response to SARS-CoV-2 Vaccines. Biomedicines 10:7, pages 1464.
Crossref
Crossref
Kakon Nag, Md. Enamul Haq Sarker, Samir Kumar, Habiba Khan, Sourav Chakraborty, Md. Jikrul Islam, Juwel Chandra Baray, Maksudur Rahman Khan, Asif Mahmud, Uttam Barman, Eleus Hussain Bhuiya, Mohammad Mohiuddin & Naznin Sultana. (2022) DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery. Scientific Reports 12:1.
Crossref
Crossref
Christopher R. Isaac. (2022) Establishing an incentive-based multistakeholder approach to dual-use DNA screening. Biochemistry and Cell Biology 100:3, pages 268-273.
Crossref
Crossref
Habtamu Endale, Saliman Aliye & Mesfin Mathewos. (2022) Vaccine epidemiology, evaluation, and constraints of vaccine effectiveness -A review. Veterinary Vaccine 1:1, pages 100004.
Crossref
Crossref
Ahmad M. Aldossary, Chinedu S.M. Ekweremadu, Ifunanya M. Offe, Haya A. Alfassam, Sooyeon Han, Vivian C. Onyali, Chukwuebuka H. Ozoude, Emmanuel A. Ayeni, Chinekwu S. Nwagwu, Abdulrahman A. Halwani, Nada H. Almozain & Essam A. Tawfik. (2022) A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development. Saudi Pharmaceutical Journal 30:6, pages 655-668.
Crossref
Crossref
Li-Juan Duan, Qian Wang, Cuilian Zhang, Dong-Xiao Yang & Xu-Yao Zhang. (2022) Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Janet M. Sasso, Barbara J. B. Ambrose, Rumiana Tenchov, Ruchira S. Datta, Matthew T. Basel, Robert K. DeLong & Qiongqiong Angela Zhou. (2022) The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments. Journal of Medicinal Chemistry 65:10, pages 6975-7015.
Crossref
Crossref
Shugang Qin, Xiaoshan Tang, Yuting Chen, Kepan Chen, Na Fan, Wen Xiao, Qian Zheng, Guohong Li, Yuqing Teng, Min Wu & Xiangrong Song. (2022) mRNA-based therapeutics: powerful and versatile tools to combat diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Cong Liu, Nino Rcheulishvili, Zhigao Shen, Dimitri Papukashvili, Fengfei Xie, Ziqian Wang, Xingyun Wang, Yunjiao He & Peng George Wang. (2022) Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants. Pharmaceutics 14:5, pages 1101.
Crossref
Crossref
William McKinley. (2022) Doomsdays and New Dawns: Technological Discontinuities and Competence Ecosystems. Academy of Management Perspectives 36:2, pages 729-743.
Crossref
Crossref
Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Irfan, Huining He, Jin Chang, Xing-Jie Liang, Yuhua Weng & Yuanyu Huang. (2022) mRNA vaccines for COVID-19 and diverse diseases. Journal of Controlled Release 345, pages 314-333.
Crossref
Crossref
Kamil BATUR & Hakan YARDIMCI. (2022) mRNA AŞILARINDA GÜNCEL YAKLAŞIMLARCURRENT APPROACHES to mRNA VACCINES. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 13:1, pages 1-10.
Crossref
Crossref
Hoor Zubda-tul & Qadir Muhammad. (2022) mRNA based vaccines as an alternative to conventional vaccine approaches. Open Journal of Environmental Biology 7:1, pages 001-005.
Crossref
Crossref
Zhan Zhang, Qi Shen & Haocai Chang. (2022) Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects. Frontiers in Immunology 13.
Crossref
Crossref
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, Maria Elsa Gambuzza, Claudio Pulvirenti, Annalisa Cozza, Andrea Corsonello, Filippo Luciani & Giovanni Rezza. (2022) COVID-19 Vaccines: Current and Future Perspectives. Vaccines 10:4, pages 608.
Crossref
Crossref
Christine M. Akamine & Hana M. El Sahly. (2022) Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review. Translational Research 242, pages 1-19.
Crossref
Crossref
Jia Tan, Binbin Ding, Bo Teng, Ping'an Ma & Jun Lin. (2022) Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine Efficacy. Advanced Functional Materials 32:16.
Crossref
Crossref
Mahender Aileni, Gulab Khan Rohela, Phanikanth Jogam, Shakuntala Soujanya & Baohong Zhang. (2022) Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms. Cells 11:7, pages 1182.
Crossref
Crossref
Enyue Fang, Xiaohui Liu, Miao Li, Zelun Zhang, Lifang Song, Baiyu Zhu, Xiaohong Wu, Jingjing Liu, Danhua Zhao & Yuhua Li. (2022) Advances in COVID-19 mRNA vaccine development. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Jianqing Wu. (2022) Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized. International Journal of Coronaviruses 4:2, pages 7-43.
Crossref
Crossref
Zoltán Kis, Kyungjae Tak, Dauda Ibrahim, Maria M. Papathanasiou, Benoît Chachuat, Nilay Shah & Cleo Kontoravdi. (2022) Pandemic-response adenoviral vector and RNA vaccine manufacturing. npj Vaccines 7:1.
Crossref
Crossref
A Mohr-Sasson, J Haas, S Abuhasira, M Sivan, H Doitch Amdurski, T Dadon, S Blumenfeld, E Derazne, R Hemi, R Orvieto, A Afek & J Rabinovici. (2022) The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels. Human Reproduction 37:3, pages 534-541.
Crossref
Crossref
Kaili Wang, Xiaoyun Wang, Di Jiang, Yifei Pei, Zhe Wang, Xiaojun Zhou, Jinglei Wu, Xiumei Mo & Hongsheng Wang. (2022) Delivery of mRNA vaccines and anti-PDL1 siRNA through non-invasive transcutaneous route effectively inhibits tumor growth. Composites Part B: Engineering 233, pages 109648.
Crossref
Crossref
Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai, YongXiang Zhao & Xing-Jie Liang. (2021) Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Research 15:3, pages 2196-2225.
Crossref
Crossref
Pier Paolo Piccaluga, Antonio Di Guardo, Anna Lagni, Virginia Lotti, Erica Diani, Mohsen Navari & Davide Gibellini. (2022) COVID-19 Vaccine: Between Myth and Truth. Vaccines 10:3, pages 349.
Crossref
Crossref
Mehdi Rasouli, Fatemeh Vakilian & Javad Ranjbari. (2022) Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical
Agents and Current Vaccines Against COVID-19. Current Stem Cell Research & Therapy 17:2, pages 166-185.
Crossref
Crossref
Sriwidodo, Abd. Kakhar Umar, Nasrul Wathoni, James H. Zothantluanga, Sanjoy Das & Jittima Amie Luckanagul. (2022) Liposome-polymer complex for drug delivery system and vaccine stabilization. Heliyon 8:2, pages e08934.
Crossref
Crossref
Sean J. Hoehn, Sarah E. Krul, Brandon J. Skory & Carlos E. Crespo‐Hernández. (2021)
Increased Photostability of the Integral mRNA Vaccine Component N
1
‐Methylpseudouridine Compared to Uridine
. Chemistry – A European Journal 28:6.
Crossref
Crossref
Qihao Zhang. Review the safety and efficacy of vaccines under the condition of COVID-19 epidemic. Review the safety and efficacy of vaccines under the condition of COVID-19 epidemic.
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Alicia Rodríguez-Gascón, Ana del Pozo-Rodríguez & María Ángeles Solinís. 2022. mRNA-Based Therapeutics. mRNA-Based Therapeutics
207
293
.
Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah Elspeth Knudsen, Farrukh Vohidov & Andoni Garitano-Trojaola. 2022. mRNA-Based Therapeutics. mRNA-Based Therapeutics
1
54
.
Rebecca Ashfield. 2022. Vaccinology and Methods in Vaccine Research. Vaccinology and Methods in Vaccine Research
281
294
.
Kanwal Gill, Leanne Minall & Aslin Rodriguez Nassif. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
157
205
.
Adrija Hajra, Manasvi Gupta, Binita Ghosh, Kumar Ashish, Neelkumar Patel, Gaurav Manek, Devesh Rai, Jayakumar Sreenivasan, Akshay Goel, Carl J. Lavie & Dhrubajyoti Bandyopadhyay. (2021) Proposed Pathogenesis, Characteristics, and Management of COVID-19 mRNA Vaccine-Related Myopericarditis. American Journal of Cardiovascular Drugs 22:1, pages 9-26.
Crossref
Crossref
Sun Chang Kim, Simranjeet Singh Sekhon, Woo-Ri Shin, Gna Ahn, Byung-Kwan Cho, Ji-Young Ahn & Yang-Hoon Kim. (2021) Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Molecular & Cellular Toxicology 18:1, pages 1-8.
Crossref
Crossref
Jiaxing Di, Zhili Du, Kangzeng Wu, Shanshan Jin, Xun Wang, Tonglei Li & Yuhong Xu. (2022) Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size. Pharmaceutical Research 39:1, pages 105-114.
Crossref
Crossref
Zikun Yang, Xiongye Xiao & Paul Bogdan. 2022. Artificial Intelligence in Covid-19. Artificial Intelligence in Covid-19
239
256
.
Melvin Sanicas, T. Anh Wartel & Merlin Sanicas. 2022. Frontiers of COVID-19. Frontiers of COVID-19
575
594
.
Begoña Alburquerque-González, María Dolores López-Abellán, Ginés Luengo-Gil, Silvia Montoro-García & Pablo Conesa-Zamora. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
165
185
.
Dennis Kobelt, Jessica Pahle & Wolfgang Walther. 2022. Gene Therapy of Cancer. Gene Therapy of Cancer
1
21
.
Steven J. Schnell, Mark Tingey & Weidong Yang. 2022. The Nuclear Pore Complex. The Nuclear Pore Complex
353
371
.
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Eleni Stamoula, Catherine K. Markopoulou, Anna Karagianni & Kyriakos Kachrimanis. (2021) mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles. Biomedicines 10:1, pages 50.
Crossref
Crossref
Xue-Liang Peng, Ji-Si-Yu Cheng, Hai-Lun Gong, Meng-Di Yuan, Xiao-Hong Zhao, Zibiao Li & Dai-Xu Wei. (2021) Advances in the design and development of SARS-CoV-2 vaccines. Military Medical Research 8:1.
Crossref
Crossref
Sudha Chivukula, Timothy Plitnik, Timothy Tibbitts, Shrirang Karve, Anusha Dias, Donghui Zhang, Rebecca Goldman, Hardip Gopani, Asad Khanmohammed, Ashish Sarode, Dustin Cooper, Heesik Yoon, Younghoon Kim, Yanhua Yan, Sophia T. Mundle, Rachel Groppo, Adrien Beauvais, Jinrong Zhang, Natalie G. Anosova, Charles Lai, Lu Li, Gregory Ulinski, Peter Piepenhagen, Joshua DiNapoli, Kirill V. Kalnin, Victoria Landolfi, Ron Swearingen, Tong-Ming Fu, Frank DeRosa & Danilo Casimiro. (2021) Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza. npj Vaccines 6:1.
Crossref
Crossref
Lisa Müller, Marcel Andrée, Wiebke Moskorz, Ingo Drexler, Lara Walotka, Ramona Grothmann, Johannes Ptok, Jonas Hillebrandt, Anastasia Ritchie, Denise Rabl, Philipp Niklas Ostermann, Rebekka Robitzsch, Sandra Hauka, Andreas Walker, Christopher Menne, Ralf Grutza, Jörg Timm, Ortwin Adams & Heiner Schaal. (2021) Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination. Clinical Infectious Diseases 73:11, pages 2065-2072.
Crossref
Crossref
Bruno Baptista, Rita Carapito, Nabila Laroui, Chantal Pichon & Fani Sousa. (2021) mRNA, a Revolution in Biomedicine. Pharmaceutics 13:12, pages 2090.
Crossref
Crossref
Pratibha Anand & Vincent P. Stahel. (2021) The safety of Covid-19 mRNA vaccines: a review. Patient Safety in Surgery 15:1.
Crossref
Crossref
Lei Miao, Yu Zhang & Leaf Huang. (2021) mRNA vaccine for cancer immunotherapy. Molecular Cancer 20:1.
Crossref
Crossref
Yang Wang, Ziqi Zhang, Jingwen Luo, Xuejiao Han, Yuquan Wei & Xiawei Wei. (2021) mRNA vaccine: a potential therapeutic strategy. Molecular Cancer 20:1.
Crossref
Crossref
Lei Li, Jinrong Long, Ye Sang, Xin Wang, Xinyang Zhou, Yufei Pan, Yiming Cao, Huiyuan Huang, Zhenjun Yang, Jing Yang & Shengqi Wang. (2021) Rational preparation and application of a mRNA delivery system with cytidinyl/cationic lipid. Journal of Controlled Release 340, pages 114-124.
Crossref
Crossref
Yuta Suzuki & Hiroshi Ishihara. (2021) Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug Metabolism and Pharmacokinetics 41, pages 100424.
Crossref
Crossref
Rebecca Glowinski, Asuncion Mejias & Octavio Ramilo. (2021) New preventive strategies for respiratory syncytial virus infection in children. Current Opinion in Virology 51, pages 216-223.
Crossref
Crossref
Banafshe Abadi, Niloufar Yazdanpanah, Ali Nokhodchi & Nima Rezaei. (2021) Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives. Advanced Drug Delivery Reviews 179, pages 114035.
Crossref
Crossref
Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque & Nihad Adnan. (2021) A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines 9:12, pages 1387.
Crossref
Crossref
Uday S. Kumar, Rayhaneh Afjei, Katherine Ferrara, Tarik F. Massoud & Ramasamy Paulmurugan. (2021) Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle. ACS Nano 15:11, pages 17582-17601.
Crossref
Crossref
Heribert Helgers, Alina Hengelbrock, Axel Schmidt & Jochen Strube. (2021) Digital Twins for Continuous mRNA Production. Processes 9:11, pages 1967.
Crossref
Crossref
Diego Centonze, Maria A. Rocca, Claudio Gasperini, Ludwig Kappos, Hans-Peter Hartung, Melinda Magyari, Celia Oreja-Guevara, Maria Trojano, Heinz Wiendl & Massimo Filippi. (2021) Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus. Journal of Neurology 268:11, pages 3961-3968.
Crossref
Crossref
Michael A. Luzuriaga, Arezoo Shahrivarkevishahi, Fabian C. Herbert, Yalini H. Wijesundara & Jeremiah J. Gassensmith. (2021) Biomaterials and nanomaterials for sustained release vaccine delivery. WIREs Nanomedicine and Nanobiotechnology 13:6.
Crossref
Crossref
Rossella Sartorius, Maria Trovato, Roberta Manco, Luciana D’Apice & Piergiuseppe De Berardinis. (2021) Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines. npj Vaccines 6:1.
Crossref
Crossref
Riccardo Nistri, Elena Barbuti, Virginia Rinaldi, Laura Tufano, Valeria Pozzilli, Antonio Ianniello, Fabiana Marinelli, Giovanna De Luca, Luca Prosperini, Valentina Tomassini & Carlo Pozzilli. (2021) Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases. Frontiers in Neurology 12.
Crossref
Crossref
Michal Monselise, Chia-Hsuan Chang, Gustavo Ferreira, Rita Yang & Christopher C Yang. (2021) Topics and Sentiments of Public Concerns Regarding COVID-19 Vaccines: Social Media Trend Analysis. Journal of Medical Internet Research 23:10, pages e30765.
Crossref
Crossref
Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour & Anwar Abdelanser. (2021) RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement. Vaccines 9:11, pages 1211.
Crossref
Crossref
Jiří Jaromír Klemeš, Peng Jiang, Yee Van Fan, Awais Bokhari & Xue-Chao Wang. (2021) COVID-19 pandemics Stage II – Energy and environmental impacts of vaccination. Renewable and Sustainable Energy Reviews 150, pages 111400.
Crossref
Crossref
Hadis Fathizadeh, Saman Afshar, Mahmood Reza Masoudi, Pourya Gholizadeh, Mohammad Asgharzadeh, Khudaverdi Ganbarov, Şükran Köse, Mehdi Yousefi & Hossein Samadi Kafil. (2021) SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review. International Journal of Biological Macromolecules 188, pages 740-750.
Crossref
Crossref
Displaying 200 of 349 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list